Hjem › Urotelial (overgangscelle) karcinom › Texas › The Woodlands
Kliniske studier for Urotelial (overgangscelle) karcinom i The Woodlands, TX
5 studier for Urotelial (overgangscelle) karcinom søker deltakere på steder i og rundt The Woodlands (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer
RekruttererFase 3
- Houston Methodist The Woodlands Hospital, The Woodlands
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
RekruttererFase 1
- The University of Texas MD Anderson Cancer Center - Conroe, Conroe · 11 mi unna
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
RekruttererFase 1/2
- Texas Oncology - Gulf Coast, The Woodlands
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
RekruttererFase 3
- US Oncology Research Network, The Woodlands
A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer
RekruttererFase 3
- Renovatio Clinical - The Woodlands Research Center, The Woodlands
Urotelial (overgangscelle) karcinom-studier i andre byer
- Nashville, TN23 studier
- New York City, NY22 studier
- Houston, TX19 studier
- Dallas, TX18 studier
- Edison, NJ18 studier
- Los Angeles, CA17 studier
- Queens, NY15 studier
- Chicago, IL14 studier
- Arlington, VA12 studier
- Boston, MA11 studier
- San Antonio, TX11 studier
- Austin, TX10 studier
Andre studier i The Woodlands
- Ikke-småcellet lungekreft15 studier
- Fedme12 studier
- Overvekt10 studier
- Brystkreft10 studier
- Makuladegenerasjon9 studier
- Kardiovaskulær sykdom9 studier
- Metastatisk kreft9 studier
- Type 2-diabetes7 studier
- Hjertesvikt7 studier
- Lungekreft7 studier
- Aterosklerose6 studier
- Geografisk atrofi6 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.